Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 7, 2005, Pages 332-333

  Nattel, Stanley ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Atenolol; Atrial fibrillation; Hypertension; Losartan; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; LOSARTAN; PLACEBO;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RHYTHM; HOSPITALIZATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; SHORT SURVEY; SINUS RHYTHM; STROKE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTI-ARRHYTHMIA AGENTS; ATENOLOL; ATRIAL FIBRILLATION; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTENSION; LOSARTAN; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 27944495649     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0247     Document Type: Short Survey

References (5)

1. Rockson SG and Albers GW (2004) Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 43: 929-935
2. Kannel WB et al. (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 82: 2N-9N
3. Li D et al. (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104: 2608-2614
4. Kumagai K et al. (2003) Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 41: 2197-2204
5. Vermes E et al. (2003) Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 107: 2926-2931